| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01243434 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/BF01243434/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/BF01243434 | ||
| http://link.springer.com/content/pdf/10.1007/BF01243434.pdf | ||
| P698 | PubMed publication ID | 164522 |
| P2093 | author name string | K. Modigh | |
| P2860 | cites work | The biochemistry of affective disorders | Q34203596 |
| Mode of Action of Psychomotor Stimulant Drugs | Q34222877 | ||
| Adrenergic mechanisms | Q39891277 | ||
| The effect of repeated electroconvulsive shock on avoidance conditioning and brain monoamine oxidase activity | Q43563106 | ||
| Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity | Q44492568 | ||
| Persisting effects of chronic electroshock seizures on brain and behavior in two strains of rats | Q48895977 | ||
| Evidence for a central noradrenaline receptor stimulation by clonidine | Q48922118 | ||
| Evidence for dopamine receptor stimulation by apomorphine. | Q51208002 | ||
| Interrelationships between electroshock, the blood-brain barrier, and catecholamines | Q51310519 | ||
| Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats | Q67218875 | ||
| Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity | Q69071274 | ||
| Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity | Q69522654 | ||
| Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines | Q69802849 | ||
| Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine | Q69818462 | ||
| Chronic administration of electroconvulsive shock and norepinephrine metabolism in the rat brain. 3. Influence of acute and chronic electroshock upon drug induced behavior | Q71238567 | ||
| Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern | Q73017819 | ||
| Clinical correlates of electroshock therapy | Q77108150 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurology | Q83042 |
| apomorphine | Q269111 | ||
| P304 | page(s) | 19-32 | |
| P577 | publication date | 1975-01-01 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS | |
| Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS | |||
| P478 | volume | 36 |
| Q41531201 | A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions |
| Q71193915 | Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour |
| Q49125373 | Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT. |
| Q48856290 | Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches |
| Q71479809 | D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function |
| Q73094000 | Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific region of the rat striatum after electroconvulsive stimuli |
| Q43745072 | Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment |
| Q40167753 | Dopamine and depression: A review of recent evidence. II. Theoretical approaches |
| Q40139757 | Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments |
| Q72378745 | Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment |
| Q41141018 | Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens |
| Q40747144 | Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine |
| Q70795365 | Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat |
| Q39080630 | Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs |
| Q67329851 | Electroconvulsive therapy |
| Q64813443 | Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon |
| Q70490989 | Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain |
| Q68695542 | Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice |
| Q39662597 | Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy |
| Q70808294 | Enhanced growth hormone response to clonidine after repeated electroconvulsive shock in a primate species |
| Q40086791 | Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine |
| Q48356782 | Influence of 6-hydroxydopamine on the behavioral effects induced by apomorphine or clonidine in rats |
| Q36586033 | Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease |
| Q48363382 | Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines |
| Q67547516 | MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice |
| Q39472392 | Mechanism of the antidepressant action of electroconvulsive therapy |
| Q54525200 | Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. |
| Q54049344 | Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. |
| Q28336187 | Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain |
| Q70161120 | Pharmacology of the human iris: development and use of challenge strategies in the study of antidepression response |
| Q48349477 | Piperidine: effects on locomotor activity and brain monoamine turnover |
| Q51846406 | Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness |
| Q64786855 | Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms |
| Q67296295 | Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock |
| Q40049586 | Relevance of the enhanced 5-hydroxytryptamine behavioural responses in rats to electroconvulsive therapy [proceedings] |
| Q68082551 | Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats |
| Q60644675 | Repeated administration of subconvulsant doses of GABA antagonist drugs |
| Q40212690 | Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens |
| Q71548675 | Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine |
| Q40050309 | Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses |
| Q41736922 | Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy |
| Q66908763 | The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists |
| Q71530599 | The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat |
| Q51864074 | The effect of repeated electroconvulsive shocks on growth hormone secretion and growth hormone responses to clonidine in the intact rat. |
| Q39310375 | The effects of drugs on the processes regulating the functional activity of brain monoamines |
| Q39271303 | The scientific status of electro-convulsive therapy |
| Q67040026 | Treatment of depression |
| Q28236515 | Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression |
Search more.